Broken String

Broken String has developed a new method to precisely map off-target effects of gene therapies without biases. This can be used to determine the mechanism of genome editing and to facilitate safer development of gene therapeutics.

Founded by Dr. Felix Dobbs, Prof. Simon Reed, Dr. Patrick van Eijk and Simon Kerr // Investment in September 2021

Latest news


DvH Ventures invests seven-figure sum in Broken String Biosciences